Biotech · Public company · Emeryville, CA, US
4D Molecular Therapeutics, Inc.
Ticker FDMT · SEC CIK 0001650648
Track this companyFree. Adds 4D Molecular Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials109 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline16
- 4D-150 IVT (3E10 vg/eye)Phase 3 · Macular Neovascularization Secondary to Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- 4D-150 IVT (3E10 vg/eye)Phase 3 · Neovascular Age-Related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- 4D-150 IVT (3x10^10 vg)Phase 3 · Diabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- EYELEA ® (aflibercept) Injection 2 mg (0.05mL)Phase 3 · Diabetic Macular Edema (DME)ClinicalTrials.gov · fetched Nov 12, 2026
- EYLEA® (aflibercept) Injection 2 mg (0.05mL)Phase 3 · Neovascular Age-Related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- EYLEA® (aflibercept) Injection 2 mg (0.05mL)Phase 3 · Macular Neovascularization Secondary to Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- 4D-125 IVT InjectionPhase 2 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- 4D-150 IVTPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- 4D-150 IVTPhase 2 · Neovascular (Wet) Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- 4D-310Phase 2 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 4D-710Phase 2 · Cystic Fibrosis LungClinicalTrials.gov · fetched Nov 12, 2026
- Aflibercept IVTPhase 2 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Aflibercept IVTPhase 2 · Neovascular (Wet) Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- ObservationalPhase 2 · X-Linked Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- 4D-110Phase 1 · ChoroideremiaClinicalTrials.gov · fetched Nov 12, 2026
- ObservationChoroideremiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).PHASE3 · RECRUITING · started Sep 18, 2026ClinicalTrials.gov NCT07867080 · fetched Nov 12, 2026
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationPHASE3 · RECRUITING · started Jul 22, 2025ClinicalTrials.gov NCT07064759 · fetched Nov 12, 2026
- 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 3, 2025ClinicalTrials.gov NCT06864988 · fetched Nov 12, 2026
- 4D-150 in Patients With Diabetic Macular EdemaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 9, 2023ClinicalTrials.gov NCT05930561 · fetched Nov 12, 2026
- 4D-710 in Adult Patients With Cystic FibrosisPHASE2 · RECRUITING · started Mar 29, 2022ClinicalTrials.gov NCT05248230 · fetched Nov 12, 2026
- 4D-150 in Patients With Neovascular (Wet) Age-Related Macular DegenerationPHASE1_PHASE2 · RECRUITING · started Dec 9, 2021ClinicalTrials.gov NCT05197270 · fetched Nov 12, 2026
- An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry DiseasePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 1, 2020ClinicalTrials.gov NCT04519749 · fetched Nov 12, 2026
- 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 9, 2020ClinicalTrials.gov NCT04517149 · fetched Nov 12, 2026
- Dose Escalation Study of Intravitreal 4D-110 in Patients With ChoroideremiaPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 2, 2020ClinicalTrials.gov NCT04483440 · fetched Nov 12, 2026
- "Natural History" Study of ChoroideremiaTERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT02994368 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 26, 2026 · fetched Nov 12, 2026